Chapter Education Programs
The Leukemia & Lymphoma Society (LLS) sponsors free community-based education programs designed for patients and their families.
National and local experts, including doctors and other healthcare professionals, lead these programs, described below. They offer education and information that will deepen the public's understanding of treatment options and strengthen decision-making and coping skills related to the many aspects of survivorship.
For more information about these programs in your area, complete the form below.
Can't make it to one of our local programs? We also sponsor many free live and past telephone/web education programs, podcasts and more that you can attend from home. Get a complete list of LLS programs.
Staying Connected
Facilitating the Learning Experience During and After Cancer Treatment
This program discusses:
- Cancers that affect children, adolescents and young adults (AYAs)
- Side effects, long term and late effects of childhood/AYA cancer treatment
- Challenges for survivors throughout their education
- Laws that protect childhood/AYA cancer survivors' rights
- Strategies to help meet the students' short- and long-term educational needs
- Resources that support schools and families, including those from The Leukemia & Lymphoma Society
Registration for this free program is required. To register, please fill out the form below.
Cancer Treatment
How to Make Informed Choices about Standard Care and Clinical Trials
This program discusses:
- Steps to take to help you make treatment decisions
- Questions to ask about benefits and risks of standard treatments and treatments under study in clinical trials
- How new blood cancer treatments are developed and approved
- How to sort out the myths from the facts about clinical trials
- How to locate clinical trials that may be right for you
- How The Leukemia & Lymphoma Society can help
Registration for this free program is required. To register, please fill out the form below.
Supported by grants from Celgene Corporation, GlaxoSmithKline, and Millennium: The Takeda Oncology Company.
